148 related articles for article (PubMed ID: 6319838)
1. [Ranitidine and cimetidine in Zollinger-Ellison syndrome].
Ribera E; González-Atienza J
Med Clin (Barc); 1983 Dec; 81(20):924-5. PubMed ID: 6319838
[No Abstract] [Full Text] [Related]
2. [Cimetidine, ranitidine and somatostatin in the medical treatment of acute and chronic Zollinger-Ellison syndrome].
Gordillo J; Varas MJ
Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):749-50. PubMed ID: 2894045
[No Abstract] [Full Text] [Related]
3. Cimetidine versus ranitidine for refractory Zollinger-Ellison syndrome.
de Gara CJ; Gledhill T; Hunt RH
Can Med Assoc J; 1984 Mar; 130(5):550, 554. PubMed ID: 6321004
[No Abstract] [Full Text] [Related]
4. Control of metastatic Zollinger-Ellison syndrome with high-dose H2-receptor antagonists.
Johnston SR; Wright PL
Br J Clin Pract; 1990 Dec; 44(12):792-3. PubMed ID: 2102253
[No Abstract] [Full Text] [Related]
5. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
Habal FM; Soldin SJ; Greenberg GR
Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine vs ranitidine.
Montgomery H
J Kans Med Soc; 1983 Dec; 84(12):605. PubMed ID: 6317776
[No Abstract] [Full Text] [Related]
7. [Cimetidine or ranitidine?].
Lamers CB
Ned Tijdschr Geneeskd; 1986 Apr; 130(16):716-9. PubMed ID: 3012376
[No Abstract] [Full Text] [Related]
8. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
9. [The role of H2 antagonists in Zollinger-Ellison syndrome].
Dammann HG; Walter TA; Müller P; Simon B
Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434
[No Abstract] [Full Text] [Related]
10. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
11. The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome.
Howard TJ; Passaro E
Surg Annu; 1990; 22():93-106. PubMed ID: 2408174
[No Abstract] [Full Text] [Related]
12. Ranitidine and cimetidine in Zollinger-Ellison syndrome.
Mignon M; Vallot T; Mayeur S; Bonfils S
Br J Clin Pharmacol; 1980 Aug; 10(2):173-4. PubMed ID: 6107118
[No Abstract] [Full Text] [Related]
13. [H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
Hotz J
Fortschr Med; 1984 Feb; 102(8):203-4. PubMed ID: 6086477
[No Abstract] [Full Text] [Related]
14. [Ranitidine].
Acero D
Med Clin (Barc); 1983 Jul; 81(4):171-7. PubMed ID: 6312209
[No Abstract] [Full Text] [Related]
15. Uncertainties in the management of the Zollinger-Ellison Syndrome.
Malagelada JR
Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
[No Abstract] [Full Text] [Related]
16. Ranitidine.
Strum WB
JAMA; 1983 Oct; 250(14):1894-6. PubMed ID: 6312110
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine or cimetidine.
McCarthy DM
Ann Intern Med; 1983 Oct; 99(4):551-3. PubMed ID: 6312863
[TBL] [Abstract][Full Text] [Related]
18. Management of Zollinger-Ellison syndrome.
Bonfils S; Mignon M; Landor JH
N Engl J Med; 1980 Oct; 303(16):942-3. PubMed ID: 6251369
[No Abstract] [Full Text] [Related]
19. [Zollinger-Ellison syndrome: long-term treatment with ranitidine].
Mony M; Lavoie S; Lemire S
Union Med Can; 1986 Mar; 115(3):149-50. PubMed ID: 3705262
[No Abstract] [Full Text] [Related]
20. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
